Clinical Trials

A Phase 1b/2 Study of Selinexor (KPT-330) in Combination with Backbone Treatments for Relapsed/Refractory Multiple Myeloma


Study ID
KCP-330-017

NCT Number
NCT02343042 (Click on the NCT number for more information about the trial)

Research Study Number
2018-0937

Principle Investigator
Dr. Biran, M.D., Noa

Phase
I/II

Sponsor
Karyopharm Therapeutics


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now